Richard Andrew Jarjes-pike

Title: Richard Andrew Jarjes-Pike: Innovator in Neurodegenerative Disease Research

Introduction

Richard Andrew Jarjes-Pike is a notable inventor based in Newbury, GB. He has made significant contributions to the field of neurodegenerative disease research, particularly through his innovative work on SARM1 inhibitors. With a total of 3 patents to his name, Jarjes-Pike is recognized for his dedication to advancing medical science.

Latest Patents

Jarjes-Pike's latest patents focus on the development of inhibitors of SARM1. The first patent provides compounds and methods that are useful for inhibiting SARM1 and/or treating and/or preventing axonal degeneration. The second patent also addresses the inhibition of SARM1, specifically targeting neurodegenerative diseases or axonal degeneration. These SARM1 inhibitors are designed to reduce or inhibit the binding of NAD+ by SARM1. Additionally, the inhibitors may bind to SARM1 within a pocket that comprises one or more catalytic residues, such as a catalytic cleft of SARM1.

Career Highlights

Richard Andrew Jarjes-Pike is currently associated with Disarm Therapeutics, Inc., where he continues to work on groundbreaking research in the field of neurodegeneration. His innovative approaches have the potential to lead to significant advancements in treatment options for patients suffering from these debilitating conditions.

Collaborations

Some of his notable coworkers include Robert Owen Hughes and Rajesh Devraj. Their collaborative efforts contribute to the ongoing research and development of effective therapies in the realm of neurodegenerative diseases.

Conclusion

Richard Andrew Jarjes-Pike is a prominent figure in the field of neurodegenerative disease research, with a focus on SARM1 inhibitors. His work has the potential to make a lasting impact on the treatment of these conditions.